Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
Larkin, James, Ascierto, Paolo A, Dréno, Brigitte, Atkinson, Victoria, Liszkay, Gabriella, Maio, Michele, Mandalà, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Dutriaux, Caroline, Garbe, Claus, Sovak, Mika A, Chang, Ilsung, Choong, Nicholas, Hack, Stephen P, McArthur, Grant A, Ribas, Antoni
Published in The New England journal of medicine (13.11.2014)
Published in The New England journal of medicine (13.11.2014)
Get full text
Journal Article
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Dummer, Reinhard, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Kirkwood, John M, Chiarion Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Lesimple, Thierry, Plummer, Ruth, Dasgupta, Kohinoor, Gasal, Eduard, Tan, Monique, Long, Georgina V, Schadendorf, Dirk
Published in The New England journal of medicine (17.09.2020)
Published in The New England journal of medicine (17.09.2020)
Get full text
Journal Article
Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Ascierto, Paolo A, McArthur, Grant A, Dréno, Brigitte, Atkinson, Victoria, Liszkay, Gabrielle, Di Giacomo, Anna Maria, Mandalà, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Dutriaux, Caroline, Garbe, Claus, Yan, Yibing, Wongchenko, Matthew, Chang, Ilsung, Hsu, Jessie J, Koralek, Daniel O, Rooney, Isabelle, Ribas, Antoni, Larkin, James
Published in The lancet oncology (01.09.2016)
Published in The lancet oncology (01.09.2016)
Get full text
Journal Article
Wnt/β-catenin signaling in melanoma: preclinical rationale and novel therapeutic insights
Gongda, Xue, Romano, Emanuela, Massi, Daniela, Mandalà, Mario
Published in Cancer treatment reviews (01.09.2016)
Published in Cancer treatment reviews (01.09.2016)
Get full text
Journal Article
Statins to prevent anthracycline-related myocardial toxicity: The jury is still out
Mandalà, Mario, Bartolini, Claudia, Becattini, Cecilia
Published in European journal of internal medicine (01.08.2024)
Published in European journal of internal medicine (01.08.2024)
Get full text
Journal Article
Rational combination of cancer immunotherapy in melanoma
Mandalà, Mario, Rutkowski, Piotr
Published in Virchows Archiv : an international journal of pathology (01.04.2019)
Published in Virchows Archiv : an international journal of pathology (01.04.2019)
Get full text
Journal Article
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Ascierto, Paolo A, Del Vecchio, Michele, Mandalá, Mario, Gogas, Helen, Arance, Ana M, Dalle, Stephane, Cowey, C Lance, Schenker, Michael, Grob, Jean-Jacques, Chiarion-Sileni, Vanna, Márquez-Rodas, Iván, Butler, Marcus O, Maio, Michele, Middleton, Mark R, de la Cruz-Merino, Luis, Arenberger, Petr, Atkinson, Victoria, Hill, Andrew, Fecher, Leslie A, Millward, Michael, Khushalani, Nikhil I, Queirolo, Paola, Lobo, Maurice, de Pril, Veerle, Loffredo, John, Larkin, James, Weber, Jeffrey
Published in The lancet oncology (01.11.2020)
Published in The lancet oncology (01.11.2020)
Get full text
Journal Article
Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma
Hauschild, Axel, Dummer, Reinhard, Schadendorf, Dirk, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Lesimple, Thierry, Plummer, Ruth, Dasgupta, Kohinoor, Haas, Tomas, Shilkrut, Mark, Gasal, Eduard, Kefford, Richard, Kirkwood, John M, Long, Georgina V
Published in Journal of clinical oncology (10.12.2018)
Published in Journal of clinical oncology (10.12.2018)
Get full text
Journal Article
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma
Dummer, Reinhard, Flaherty, Keith T, Robert, Caroline, Arance, Ana, de Groot, Jan Willem B, Garbe, Claus, Gogas, Helen J, Gutzmer, Ralf, Krajsová, Ivana, Liszkay, Gabriella, Loquai, Carmen, Mandalà, Mario, Schadendorf, Dirk, Yamazaki, Naoya, di Pietro, Alessandra, Cantey-Kiser, Jean, Edwards, Michelle, Ascierto, Paolo A
Published in Journal of clinical oncology (20.12.2022)
Published in Journal of clinical oncology (20.12.2022)
Get full text
Journal Article
Nras in melanoma: Targeting the undruggable target
Mandalà, Mario, Merelli, Barbara, Massi, Daniela
Published in Critical reviews in oncology/hematology (01.11.2014)
Published in Critical reviews in oncology/hematology (01.11.2014)
Get full text
Journal Article
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism
Verso, Melina, Munoz, Andres, Bauersachs, Rupert, Huisman, Menno V., Mandalà, Mario, Vescovo, Giorgio, Becattini, Cecilia, Agnelli, Giancarlo
Published in European journal of cancer (1990) (01.05.2021)
Published in European journal of cancer (1990) (01.05.2021)
Get full text
Journal Article
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma
Dummer, Reinhard, Long, Georgina V, Robert, Caroline, Tawbi, Hussein A, Flaherty, Keith T, Ascierto, Paolo A, Nathan, Paul D, Rutkowski, Piotr, Leonov, Oleg, Dutriaux, Caroline, Mandalà, Mario, Lorigan, Paul, Ferrucci, Pier Francesco, Grob, Jean Jacques, Meyer, Nicolas, Gogas, Helen, Stroyakovskiy, Daniil, Arance, Ana, Brase, Jan C, Green, Steven, Haas, Tomas, Masood, Aisha, Gasal, Eduard, Ribas, Antoni, Schadendorf, Dirk
Published in Journal of clinical oncology (01.05.2022)
Published in Journal of clinical oncology (01.05.2022)
Get full text
Journal Article